Kurs
+1,58%
Likviditet
126 MSEK
Kalender
Est. tid* | ||
2025-10-21 | 12:00 | Kvartalsrapport 2025-Q3 |
2025-07-18 | 12:00 | Kvartalsrapport 2025-Q2 |
2025-04-23 | - | X-dag ordinarie utdelning GETI B 4.60 SEK |
2025-04-22 | - | Årsstämma |
2025-04-22 | - | Kvartalsrapport 2025-Q1 |
2025-01-28 | - | Bokslutskommuniké 2024 |
2024-10-18 | - | Kvartalsrapport 2024-Q3 |
2024-07-18 | - | Kvartalsrapport 2024-Q2 |
2024-04-23 | - | X-dag ordinarie utdelning GETI B 4.40 SEK |
2024-04-22 | - | Årsstämma |
2024-04-22 | - | Kvartalsrapport 2024-Q1 |
2024-02-01 | - | Bokslutskommuniké 2023 |
2023-10-23 | - | Kvartalsrapport 2023-Q3 |
2023-07-18 | - | Kvartalsrapport 2023-Q2 |
2023-04-27 | - | X-dag ordinarie utdelning GETI B 4.25 SEK |
2023-04-26 | - | Årsstämma |
2023-04-26 | - | Kvartalsrapport 2023-Q1 |
2023-02-01 | - | Bokslutskommuniké 2022 |
2022-10-19 | - | Kvartalsrapport 2022-Q3 |
2022-07-19 | - | Kvartalsrapport 2022-Q2 |
2022-04-27 | - | X-dag ordinarie utdelning GETI B 4.00 SEK |
2022-04-26 | - | Årsstämma |
2022-04-26 | - | Kvartalsrapport 2022-Q1 |
2022-01-28 | - | Bokslutskommuniké 2021 |
2021-10-20 | - | Kvartalsrapport 2021-Q3 |
2021-07-16 | - | Kvartalsrapport 2021-Q2 |
2021-04-21 | - | X-dag ordinarie utdelning GETI B 3.00 SEK |
2021-04-20 | - | Årsstämma |
2021-04-20 | - | Kvartalsrapport 2021-Q1 |
2021-01-28 | - | Bokslutskommuniké 2020 |
2020-10-16 | - | Kvartalsrapport 2020-Q3 |
2020-07-16 | - | Kvartalsrapport 2020-Q2 |
2020-06-29 | - | X-dag ordinarie utdelning GETI B 1.50 SEK |
2020-06-26 | - | Årsstämma |
2020-04-22 | - | Kvartalsrapport 2020-Q1 |
2020-01-30 | - | Bokslutskommuniké 2019 |
2019-10-18 | - | Kvartalsrapport 2019-Q3 |
2019-07-17 | - | Kvartalsrapport 2019-Q2 |
2019-04-24 | - | X-dag ordinarie utdelning GETI B 1.00 SEK |
2019-04-23 | - | Årsstämma |
2019-04-23 | - | Kvartalsrapport 2019-Q1 |
2019-01-30 | - | Bokslutskommuniké 2018 |
2018-10-18 | - | Kvartalsrapport 2018-Q3 |
2018-07-17 | - | Kvartalsrapport 2018-Q2 |
2018-04-27 | - | X-dag ordinarie utdelning GETI B 1.50 SEK |
2018-04-26 | - | Årsstämma |
2018-04-26 | - | Kvartalsrapport 2018-Q1 |
2018-01-29 | - | Bokslutskommuniké 2017 |
2017-10-18 | - | Kvartalsrapport 2017-Q3 |
2017-07-17 | - | Kvartalsrapport 2017-Q2 |
2017-04-25 | - | Kvartalsrapport 2017-Q1 |
2017-03-30 | - | X-dag ordinarie utdelning GETI B 2.00 SEK |
2017-03-29 | - | Årsstämma |
2017-01-26 | - | Bokslutskommuniké 2016 |
2016-10-18 | - | Kvartalsrapport 2016-Q3 |
2016-07-14 | - | Kvartalsrapport 2016-Q2 |
2016-04-22 | - | Kvartalsrapport 2016-Q1 |
2016-03-31 | - | X-dag ordinarie utdelning |
2016-03-30 | - | Årsstämma |
2016-01-28 | - | Bokslutskommuniké 2015 |
2015-10-15 | - | Kvartalsrapport 2015-Q3 |
2015-09-02 | - | Extra Bolagsstämma 2015 |
2015-07-15 | - | Kvartalsrapport 2015-Q2 |
2015-04-20 | - | Kvartalsrapport 2015-Q1 |
2015-03-26 | - | X-dag ordinarie utdelning GETI B 2.80 SEK |
2015-03-25 | - | Årsstämma |
2015-01-28 | - | Bokslutskommuniké 2014 |
2014-10-16 | - | Analytiker möte 2014 |
2014-10-16 | - | Kvartalsrapport 2014-Q3 |
2014-07-15 | - | Kvartalsrapport 2014-Q2 |
2014-04-16 | - | Kvartalsrapport 2014-Q1 |
2014-03-21 | - | X-dag ordinarie utdelning GETI B 4.15 SEK |
2014-03-20 | - | Årsstämma |
2014-01-28 | - | Bokslutskommuniké 2013 |
2013-10-15 | - | Analytiker möte 2013 |
2013-10-15 | - | 15-7 2013 |
2013-10-15 | - | Kvartalsrapport 2013-Q3 |
2013-07-11 | - | Kvartalsrapport 2013-Q2 |
2013-04-17 | - | Kvartalsrapport 2013-Q1 |
2013-03-22 | - | X-dag ordinarie utdelning GETI B 4.15 SEK |
2013-03-21 | - | Årsstämma |
2013-02-08 | - | Kapitalmarknadsdag 2013 |
2013-01-25 | - | Bokslutskommuniké 2012 |
2012-10-17 | - | Analytiker möte 2012 |
2012-10-17 | - | Kvartalsrapport 2012-Q3 |
2012-07-11 | - | Kvartalsrapport 2012-Q2 |
2012-04-19 | - | Kvartalsrapport 2012-Q1 |
2012-03-29 | - | X-dag ordinarie utdelning GETI B 3.75 SEK |
2012-03-28 | - | Årsstämma |
2012-01-26 | - | Bokslutskommuniké 2011 |
2011-10-20 | - | Kvartalsrapport 2011-Q3 |
2011-07-11 | - | Kvartalsrapport 2011-Q2 |
2011-04-28 | - | X-dag ordinarie utdelning GETI B 3.25 SEK |
2011-04-27 | - | Årsstämma |
2011-04-27 | - | Kvartalsrapport 2011-Q1 |
2011-01-28 | - | Kapitalmarknadsdag 2011 |
2011-01-26 | - | Bokslutskommuniké 2010 |
2010-10-19 | - | Kvartalsrapport 2010-Q3 |
2010-04-23 | - | X-dag ordinarie utdelning GETI B 2.75 SEK |
2010-04-22 | - | X-dag ordinarie utdelning GETI B 2.75 SEK |
2010-04-21 | - | Årsstämma |
2010-04-21 | - | Kvartalsrapport 2010-Q1 |
2010-01-26 | - | Bokslutskommuniké 2009 |
2009-07-13 | - | Kvartalsrapport 2009-Q2 |
2009-05-06 | - | Kvartalsrapport 2009-Q3 |
2009-04-22 | - | X-dag ordinarie utdelning GETI B 2.40 SEK |
2009-04-21 | - | Årsstämma |
2009-04-21 | - | Kvartalsrapport 2009-Q1 |
2008-04-18 | - | X-dag ordinarie utdelning GETI B 2.40 SEK |
2007-04-20 | - | X-dag ordinarie utdelning GETI B 2.20 SEK |
2006-04-21 | - | X-dag ordinarie utdelning GETI B 2.00 SEK |
2005-04-20 | - | X-dag ordinarie utdelning GETI B 1.65 SEK |
2004-04-22 | - | X-dag ordinarie utdelning GETI B 1.35 SEK |
2003-11-25 | - | Split GETI B 1:4 |
2003-04-24 | - | X-dag ordinarie utdelning GETI B 4.25 SEK |
2002-04-19 | - | X-dag ordinarie utdelning GETI B 3.75 SEK |
2001-04-24 | - | X-dag ordinarie utdelning GETI B 3.50 SEK |
2000-04-28 | - | X-dag ordinarie utdelning GETI B 3.50 SEK |
1999-04-22 | - | X-dag ordinarie utdelning GETI B 3.25 SEK |
1998-04-24 | - | X-dag ordinarie utdelning GETI B 2.75 SEK |
1997-04-30 | - | X-dag ordinarie utdelning GETI B 2.50 SEK |
1996-04-19 | - | X-dag ordinarie utdelning GETI B 6.00 SEK |
Beskrivning
Land | Sverige |
---|---|
Lista | Large Cap Stockholm |
Sektor | Hälsovård |
Industri | Medicinteknik |
The SBTi's Target Validation Team today announces that Getinge's near and long-term targets are aligned with the SBTi's 1.5°C mitigation pathways for reaching net-zero by 2050 or sooner. By this, Getinge commits to reach net-zero greenhouse gas emissions across the value chain by 2050 from a 2021 base year.
"Having our targets approved by the SBTi is an important milestone on our journey to net-zero emissions," says Mattias Perjos, President & CEO, Getinge "The global healthcare sector is today alone responsible for almost 5% of global greenhouse gas emissions[1]. As a global medtech company we need to take responsibility for our emissions and the impact we have on the planet."
Near-term, Getinge commits to reduce absolute scope 1 and 2 greenhouse gas (GHG) emissions 90% by 2030 from a 2021 base year, and to reduce absolute scope 3 GHG emissions 25% within the same timeframe.
Getinge's long-term targets are to maintain at least 90% absolute scope 1 and 2 GHG emissions reductions from 2030 through 2050, and to reduce absolute scope 3 GHG emissions 90% by 2050 from a 2021 base year.
Learn more about Getinge's ambitions here (https://sciencebasedtargets.org/companies-taking-action)
Media contact:
Anna Appelqvist, Corporate Communications
Telephone: +46 (0)10 335 59 06
E-mail: anna.appelqvist@getinge.com
About Getinge
With a firm belief that every person and community should have access to the best possible care, Getinge provides hospitals and life science institutions with products and solutions aiming to improve clinical results and optimize workflows. The offering includes products and solutions for intensive care, cardiovascular procedures, operating rooms, sterile reprocessing and life science. Getinge employs over 11,000 people worldwide and the products are sold in more than 135 countries.
About the Science Based Targets initiative
The Science Based Targets initiative (SBTi) is a global body enabling businesses to set ambitious emissions reductions targets in line with the latest climate science. It is focused on accelerating companies across the world to halve emissions before 2030 and achieve net-zero emissions before 2050.
The initiative is a collaboration between CDP, the United Nations Global Compact, World Resources Institute (WRI) and the World Wide Fund for Nature (WWF) and one of the We Mean Business Coalition commitments. The SBTi defines and promotes best practice in science-based target setting, offers resources and guidance to reduce barriers to adoption, and independently assesses and approves companies' targets.
[1] www.healthpolicypartnership.com/the-nexus-between-climate-change-and-healthcare